Literature DB >> 21680038

ATM-dependent phosphorylation of 53BP1 in response to genomic stress in oxic and hypoxic cells.

Shane M Harding1, Carla Coackley, Robert G Bristow.   

Abstract

The ATM kinase is activated by chromatin modification following exogenous and endogenous DSBs or cell stress, including acute anoxia. The p53 binding protein 1 (53BP1) contains multiple ATM-consensus phosphorylation sites in its N- and C-termini and may therefore be a distal read-out of ATM function. We have examined the cellular activation of these phosphorylation sites for the first time in situ following anoxic/hypoxic stress and IR-induced exogenous DSBs. We show that multiple residues of 53BP1 are phosphorylated and that these phosphoforms form discrete nuclear foci following IR or during DNA replication as exogenous or endogenous DNA double strand breaks (DSBs), respectively. Novel data pertaining to the phosphorylation of 53BP1(Ser25)in situ supports its dependency on the ATM kinase; but this occurs independently of p53 function. We show that 53BP1(Ser25) is activated specifically in S-phase cells during anoxia in an ATM-dependent manner. Exogenous DSBs form discrete IR-induced foci whereas oxygen stress induced non-localized 53BP1(Ser25) activation. Our in vitro data are supported by irradiated xenograft studies in vivo whereby 53BP1(Ser25) phosphorylation does not occur in sub-regions positive for the hypoxia marker EF5. We propose a model whereby DSBs induce chromatin modification at sites of DNA damage which are tracked by the ATM substrates γ H2AX and 53BP1(Ser25) in a mechanism distinct from p53-mediated cell cycle arrest. Together this work indicates 53BP1(Ser25), and possibly other 53BP1 phosphoforms, as a bona fide DSB-biomarkers for surveying ongoing DNA-damage related signaling in oxic and hypoxic cells during clinical radiotherapy.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680038     DOI: 10.1016/j.radonc.2011.05.039

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Recurrent DNA damage is associated with persistent injury in progressive radiation-induced pulmonary fibrosis.

Authors:  Tyler A Beach; Angela M Groves; Carl J Johnston; Jacqueline P Williams; Jacob N Finkelstein
Journal:  Int J Radiat Biol       Date:  2018-09-21       Impact factor: 2.694

Review 2.  Telomere Maintenance and the cGAS-STING Pathway in Cancer.

Authors:  Hiroshi Ebata; Tze Mun Loo; Akiko Takahashi
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

3.  Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells.

Authors:  Pratikkumar H Vekaria; Amar Kumar; Dharmalingam Subramaniam; Neil Dunavin; Anusha Vallurupalli; Frank Schoenen; Siddhartha Ganguly; Shrikant Anant; Joseph P McGuirk; Roy A Jensen; Rekha Rao
Journal:  Leukemia       Date:  2019-01-21       Impact factor: 11.528

4.  Persistent DNA damage after high dose in vivo gamma exposure of minipig skin.

Authors:  Emad A Ahmed; Diane Agay; Gerrit Schrock; Michel Drouet; Viktor Meineke; Harry Scherthan
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

5.  Tumor hypoxia as a driving force in genetic instability.

Authors:  Kaisa R Luoto; Ramya Kumareswaran; Robert G Bristow
Journal:  Genome Integr       Date:  2013-10-24

6.  Nuclear GSK3β induces DNA double-strand break repair by phosphorylating 53BP1 in glioblastoma.

Authors:  Yong Yang; Tiantian Lei; Suya Du; Rongsheng Tong; Hailian Wang; Jiao Yang; Juan Huang; Minghan Sun; Yi Wang; Zhi Dong
Journal:  Int J Oncol       Date:  2018-01-04       Impact factor: 5.650

7.  ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner.

Authors:  Yi-Ru Pan; Chiao-En Wu; Chun-Nan Yeh
Journal:  Biomolecules       Date:  2020-11-09

8.  A Lack of Effectiveness in the ATM-Orchestrated DNA Damage Response Contributes to the DNA Repair Defect of HPV-Positive Head and Neck Cancer Cells.

Authors:  Sabrina Köcher; Henrike Barbara Zech; Leonie Krug; Fruzsina Gatzemeier; Sabrina Christiansen; Felix Meyer; Ruth Rietow; Nina Struve; Wael Yassin Mansour; Malte Kriegs; Cordula Petersen; Christian Betz; Kai Rothkamm; Thorsten Rieckmann
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.